Key result
Overexpression of lncRNA NR_038323 suppressed high glucose-induced renal fibrosis via the miR-324-3p/DUSP1/p38MAPK and ERK1/2 axis in diabetic nephropathy models.
Why the study?
The exact role and regulatory mechanism of lncRNA NR_038323 in diabetic nephropathy remained largely unclear.
Does lncRNA NR_038323 overexpression prevent renal fibrosis in diabetic nephropathy models?
Does lncRNA NR_038323 overexpression prevent renal fibrosis in diabetic nephropathy models?
lncRNA NR_038323 suppresses renal fibrosis in diabetic nephropathy by targeting the miR-324-3p/DUSP1 axis, providing a potential novel therapeutic target.
Potential antifibrotic target in diabetic nephropathy; leaves open clinical translation.
Several studies have suggested that long intergenic noncoding RNAs are involved in the progression of diabetic nephropathy (DN). However, the exact role and regulatory mechanism of long noncoding RNA (lncRNA) NR_038323 in diabetic nephropathy (DN) remain largely unclear. In the present study, we found that lncRNA NR_038323 overexpression ameliorated the high glucose (HG)-induced expression levels of collagen I, collagen IV, and fibronectin, whereas lncRNA NR_038323 knockdown exerted the opposite effects. Moreover, the results of bioinformatic prediction, luciferase assay, and fluorescence in situ hybridization (FISH) demonstrated that lncRNA NR_038323 directly interacted with miR-324-3p. Additionally, miR-324-3p mimic aggravated the HG-induced expression levels of collagen I, collagen IV, and fibronectin by dual-specificity protein phosphatase-1 (DUSP1) expression to activate p38 mitogen-activated protein kinase (MAPK) and ERK1/2 pathways. In contrast, overexpression of DUSP1 attenuated the HG-induced expression levels of collagen I, collagen IV, and fibronectin via inactivation of p38 MAPK and ERK1/2 pathways. In addition, lncRNA NR_038323 knockdown increased the expression levels of collagen I, collagen IV, and fibronectin by upregulating DUSP1 expression during HG treatment, which were markedly reversed by miR-324-3p inhibitor. Furthermore, these molecular changes were verified in the human kidney samples of DN patients. Finally, overexpression of lncRNA NR_038323 ameliorated the interstitial fibrosis in STZ-induced diabetic nephrology (DN) rat via miR-324-3p/DUSP1/p38MAPK and ERK1/2 axis. In conclusion, our data indicate that overexpression of lncRNA NR_038323 may suppress HG-induced renal fibrosis via the miR-324-3p/DUSP1/p38MAPK and ERK1/2 axis, which provides new insights into the pathogenesis of DN.
No takes yet. Share an insight, caveat, or question.
Ge et al. (2019) studied Diabetic nephropathy. lncRNA NR_038323 overexpression vs. lncRNA NR_038323 knockdown / control was evaluated on Renal fibrosis (expression levels of collagen I, collagen IV, and fibronectin). Overexpression of lncRNA NR_038323 suppressed high glucose-induced renal fibrosis via the miR-324-3p/DUSP1/p38MAPK and ERK1/2 axis in diabetic nephropathy models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: